High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells

Metformin, the most widely prescribed anti-diabetic drug, is shown to possess anti-cancer potential in treatment of cancers, including breast cancer; decreases breast cancer risk; and improves overall survival. However, reports suggest that higher glucose concentrations may negatively impact the ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Varghese, Sharon, Samuel, Samson Mathews, Varghese, Elizabeth, Kubatka, Peter, Büsselberg, Dietrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359242/
https://www.ncbi.nlm.nih.gov/pubmed/30626087
http://dx.doi.org/10.3390/biom9010016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359242/
https://www.ncbi.nlm.nih.gov/pubmed/30626087
http://dx.doi.org/10.3390/biom9010016

Ejemplares similares